WallStreetZenWallStreetZen

NYSE: GKOS
Glaukos Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for GKOS

Based on 6 analysts offering 12 month price targets for Glaukos Corp.
Min Forecast
$44.00-25.21%
Avg Forecast
$55.33-5.94%
Max Forecast
$71.00+20.69%

Should I buy or sell GKOS stock?

Based on 6 analysts offering ratings for Glaukos Corp.
Buy
Strong Buy
2 analysts 33.33%
Buy
1 analysts 16.67%
Hold
3 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GKOS stock forecasts and price targets.

GKOS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Stephens & Co.
Bottom 17%
17
Strong BuyReiterates$71.00+20.69%2023-05-08
Needham
Top 36%
65
BuyMaintains$58.00-1.41%2023-05-04
Mizuho
Top 9%
92
HoldMaintains$52.00-11.61%2023-04-18
JP Morgan
Top 44%
57
HoldMaintains$48.00-18.41%2023-02-23
Citigroup
Top 3%
98
Strong BuyMaintains$59.00+0.29%2023-02-23
Wells Fargo
Top 8%
93
HoldMaintains$44.00-25.21%2022-12-12

1 of 1

Forecast return on equity

Is GKOS forecast to generate an efficient return?
Company
N/A
Industry
0.51%
Market
71.27%

Forecast return on assets

Is GKOS forecast to generate an efficient return on assets?
Company
N/A
Industry
0.22%

GKOS revenue growth forecast

How is GKOS forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
14.46%
Industry
6.6%
Market
8.44%
GKOS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GKOS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GKOS vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
GKOS$58.83$55.33-5.94%Buy
STAA$57.78$73.33+26.92%Buy
IRTC$110.35$150.88+36.72%Strong Buy
ATRC$45.78$59.25+29.42%Strong Buy
LMAT$64.02$62.00-3.16%Buy
View Top Medical Stocks

Glaukos Stock Forecast FAQ

Is Glaukos Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: GKOS) stock is to Buy GKOS stock.

Out of 6 analysts, 2 (33.33%) are recommending GKOS as a Strong Buy, 1 (16.67%) are recommending GKOS as a Buy, 3 (50%) are recommending GKOS as a Hold, 0 (0%) are recommending GKOS as a Sell, and 0 (0%) are recommending GKOS as a Strong Sell.

If you're new to stock investing, here's how to buy Glaukos stock.

What is GKOS's forecast return on equity (ROE) for 2023-2026?

(NYSE: GKOS) forecast ROE is N/A, which is considered weak.

What is GKOS's Price Target?

According to 6 Wall Street analysts that have issued a 1 year GKOS price target, the average GKOS price target is $55.33, with the highest GKOS stock price forecast at $71.00 and the lowest GKOS stock price forecast at $44.00.

On average, Wall Street analysts predict that Glaukos's share price could fall to $55.33 by May 8, 2024. The average Glaukos stock price prediction forecasts a potential downside of 5.94% from the current GKOS share price of $58.83.

What is GKOS's forecast return on assets (ROA) for 2023-2026?

(NYSE: GKOS) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 0.22%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.